Halo Nevus: Benign Mole or a Sign of Melanoma?

A halo nevus is, in the vast majority of cases, a completely benign mole undergoing a slow, immune-driven self-destruction. It shows up as an ordinary mole encircled by a distinctive ring of pale or white skin, and it occurs most often in children and teenagers. The immune system is essentially recognizing the mole’s pigment cells as foreign and dismantling them. Rarely, though, a melanoma undergoing regression can mimic that same halo appearance, and the distinction matters enough that dermatologists pay close attention to certain details before dismissing a halo nevus as harmless.

What Creates the White Ring

The pale halo forms because immune cells move into the area around and within a mole and start attacking its melanocytes, the cells responsible for pigment. The key players are CD8+ T cells, a type of white blood cell that targets and destroys specific cells. In tissue samples from halo nevi, these CD8+ T cells outnumber other immune cell types, and the infiltrate of natural killer cells is generally not substantial. Circulating antibodies against nevus cells have also been detected, suggesting both arms of the immune system may participate in the process.

1Archives of Dermatology. Halo Congenital Nevus Undergoing Spontaneous Regression: Involvement of T-Cell Immunity in Involution and Presence of Circulating Anti—Nevus Cell IgM Antibodies

Researchers have also found elevated levels of the chemokine CXCL10 and its receptor CXCR3 in halo nevus skin, along with increased hydrogen peroxide. These are the same inflammatory signals found in vitiligo lesions, and the hydrogen peroxide concentration correlates with the level of CXCL10 present, hinting at a feedback loop between oxidative stress and immune recruitment.

2PubMed. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus

The whole cycle typically unfolds over months to years in four recognizable stages. First, a pale rim appears around what looks like a perfectly normal mole. Then the mole itself starts losing color, turning pink or flesh-toned before gradually fading away entirely. What remains is a round or oval patch of depigmented skin. Over time, even that patch fills back in with normal pigment, and the skin looks as if nothing was ever there. Multiple halo nevi can appear at different stages simultaneously, so a person might have one mole just developing its halo while another has already vanished.

The Vitiligo Connection

Halo nevi and vitiligo are immunological cousins. Both conditions involve the immune system attacking melanocytes, and biopsy samples from both show strikingly similar profiles: pronounced CD8+ T cell infiltrates, elevated inflammatory markers like granzyme B and perforin, and the same CXCL10/hydrogen peroxide signaling.

2PubMed. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus

People who develop halo nevi are more likely to go on to develop vitiligo than the general population, though not everyone does. A study of 212 halo nevus patients found that three factors independently predicted later vitiligo: the Koebner phenomenon (where new skin lesions form at sites of trauma), having multiple halo nevi rather than just one, and a family history of vitiligo. Among these, the Koebner phenomenon was the strongest predictor.

3PubMed Central. Factors Associated with Development of Vitiligo in Patients with Halo Nevus

Despite the overlap, the two conditions are not genetically identical. Studies of immune-system genes have found that halo nevi associated with vitiligo show different patterns of HLA (human leukocyte antigen) associations compared to vitiligo on its own. For instance, vitiligo vulgaris has a positive association with HLA-DR4, while halo nevi associated with vitiligo do not share that link but instead show a distinct negative association with HLA-DR11. The researchers concluded that the two conditions likely have distinct underlying mechanisms even though their surface-level immune responses look alike.

4PubMed. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study

One way to think about it: in a halo nevus, the immune system is targeting abnormal melanocytic cells (the nevus cells) specifically. In vitiligo, it is targeting normal melanocytes more broadly. A halo nevus may represent the immune system’s initial attack on nevus cells, with collateral damage then spreading to surrounding normal melanocytes, potentially kickstarting a wider vitiligo process in susceptible individuals.

5JAMA Dermatology. Halo Nevi Association in Nonsegmental Vitiligo Affects Age at Onset and Depigmentation Pattern

When a Halo Might Actually Be Melanoma

This is the question that gives dermatologists pause. Although rare, melanomas can undergo immune-mediated regression and produce a clinical picture that looks like an ordinary halo nevus. Two case reports of young patients described regressed primary melanomas that were initially mistaken for benign halo nevi.

6PubMed Central. Halo Nevi Are Not Trivial: About 2 Young Patients of Regressed Primary Melanoma That Simulates Halo Nevi

Another concern is that halo nevi can occasionally signal a melanoma located elsewhere on the body. A case series of post-adolescent patients who developed sudden, eruptive halo nevi found melanoma in four of the patients, including three with primary cutaneous melanoma and one with melanoma metastasis from an unknown primary site. The incidence of melanoma in that group was roughly 955 times higher than what would be expected in the general population of the same age.

7PubMed Central. Eruptive Halo Naevi: A Possible Indicator of Malignant Disease in a Case Series of Post-Adolescent Patients

The evidence here comes from small case series, so the actual risk for any individual halo nevus patient remains very low. But the pattern is worth knowing about: eruptive halo nevi appearing for the first time in an adult, particularly someone past their twenties, deserve a careful skin examination to look for melanoma elsewhere.

How Dermatologists Tell the Difference

The first tool is dermoscopy, a handheld magnification device that lets a clinician see structures within the skin that are invisible to the naked eye. A typical benign halo nevus shows a symmetric, homogeneous pattern under dermoscopy, with an even distribution of color and structure. Melanoma with regression looks dramatically different: a study found that dermoscopy of melanomas mimicking halo nevi revealed a multicomponent pattern characterized by marked asymmetry of structures, including atypical pigment networks, blue-white veil, irregular dots and globules, streaks, and regression structures, with colors ranging from white to brown to blue to black.

8JAMA Dermatology. Dermoscopy Patterns of Halo Nevi

When dermoscopy is not enough to settle the question, a biopsy provides a definitive answer. Under the microscope, both halo nevi and regressing melanomas show dense lymphocytic infiltrates that can obscure and replace the original pigment cells. The two can look deceptively similar at first glance.

9Actas Dermo-Sifiliográficas. Inflammatory Cell Immunophenotypes in Regressing Melanomas and Halo Nevi: Possible Keys to Distinguish Intensely Inflamed Tumors

Specialized staining techniques can reveal the critical differences, though. Halo nevi have a higher number of active cytotoxic T cells (TIA-1 positive) and regulatory PD1-positive T cells compared to melanomas with regression. The ratio of a specific dendritic cell marker (CD123) to TIA-1 staining was higher in melanomas than in halo nevi, offering pathologists a potential tool for distinguishing the two when the standard microscopic picture is ambiguous.

10The American Journal of Dermatopathology. Study of the Immunophenotype of the Inflammatory Cells in Melanomas With Regression and Halo Nevi

When Biopsy Is Warranted

Most halo nevi in children and teenagers do not need a biopsy. A typical-looking halo around a symmetric, evenly colored mole in a twelve-year-old is almost certainly benign and can simply be monitored. The clinical scenarios that raise concern and push toward biopsy include:

  • Adult onset: Halo nevi developing for the first time in someone over 30 or 40 are unusual enough to warrant closer inspection.
  • Solitary lesion: A single halo nevus with no personal or family history of vitiligo is more suspicious than multiple halo nevi, which tend to reflect a broader autoimmune tendency.
  • Asymmetry or irregular features: If the central mole looks uneven in shape, has multiple colors, or shows irregular borders, dermoscopy and possibly biopsy are appropriate.
  • Symptomatic changes: A history of itching, pain, spontaneous bleeding, or rapid changes in the mole’s appearance before the halo developed should prompt investigation.
  • Eruptive pattern: The sudden appearance of many halo nevi in an adult warrants a full-body skin examination to rule out melanoma elsewhere.

Researchers studying cases where melanoma masqueraded as a halo nevus have emphasized the importance of a detailed history. In one report, a patient’s melanoma had already fully regressed by the time it was evaluated, but the patient recalled that the lesion had previously been entirely black and had changed over time. That kind of history can be the difference between reassurance and a potentially lifesaving biopsy.

6PubMed Central. Halo Nevi Are Not Trivial: About 2 Young Patients of Regressed Primary Melanoma That Simulates Halo Nevi

Sunburn, Trauma, and Stress as Triggers

Halo nevi do not appear entirely at random. Intense sun exposure, especially sunburns, has been linked to their development. The working theory is that UV-induced damage to melanocytes makes them more recognizable to the immune system, tipping off the attack that creates the halo.

11PubMed. “Halo nevi” and UV radiation

Local trauma to the skin can similarly trigger the process, possibly by causing enough cellular stress to expose antigens that the immune system then flags as abnormal. Psychosocial stress has also been associated with halo nevus onset, though the mechanism linking emotional stress to a localized skin immune response remains poorly understood. These triggers reinforce the idea that halo nevi represent an immune event that can be set off by various forms of cellular or systemic disturbance.

When Immunotherapy Creates Halo Nevi

Patients receiving immune checkpoint inhibitors for cancer sometimes develop halo nevi as a treatment side effect. These drugs work by removing the brakes on the immune system, allowing it to attack cancer cells more aggressively. In the process, the revved-up immune system sometimes turns on melanocytes as well, producing depigmentation, white patches of skin, and halo nevi.

This was initially documented mainly in metastatic melanoma patients, which made intuitive sense since the immune system was already being primed against melanocyte-derived cancer cells. But cases have since appeared in patients with other cancers as well. One report described a lung cancer patient treated with atezolizumab, a PD-L1 antibody, who developed leukoderma presenting as halo nevi despite having no melanoma at all.

12Journal of Drugs in Dermatology. Development of Halo Nevi in a Lung Cancer Patient: A Novel Immune-Related Cutaneous Event from Atezolizumab

For melanoma patients specifically, the development of skin depigmentation or halo nevi during immunotherapy is generally considered a favorable sign. It suggests the immune system is mounting a robust response against melanocyte-related antigens, and studies have linked these skin changes to better treatment outcomes. The cosmetic changes can be distressing, but oncologists typically view them as evidence that the therapy is working.

Genetic Susceptibility and HLA Associations

Not everyone who sunburns or has moles develops halo nevi, which raises the question of genetic predisposition. Research in patients with Turner syndrome, a chromosomal condition affecting about 1 in 2,000 women, has provided some clues. In a study of 72 Turner syndrome patients, those who developed halo nevi had a significantly higher frequency of the HLA-Cw6 allele compared to those who did not, with about a fivefold increase in odds. Overrepresentation of DRB1*0701 alleles was also found in the halo nevus group, suggesting a susceptibility gene located near the HLA-C region on chromosome 6.

13PubMed. Halo nevus, rather than vitiligo, is a typical dermatologic finding of turner’s syndrome: clinical, genetic, and immunogenetic study in 72 patients

These HLA genes encode proteins that present antigens to the immune system, essentially determining which cellular components the immune system learns to recognize and target. Variations in these genes help explain why some people’s immune systems are more prone to recognizing melanocyte antigens as foreign. The specific HLA associations also differ between halo nevi and vitiligo, as noted earlier, reinforcing the idea that genetic susceptibility to the two conditions runs along partially separate tracks even though their immune mechanisms overlap.

The Halo Phenomenon Beyond Moles

While halo nevi are by far the most common example, the halo reaction is not exclusive to melanocytic moles. The immune system can occasionally mount a similar depigmenting response around other types of skin lesions. A case report described a basal cell carcinoma in a young woman that developed a halo of pale skin around it, an unusual presentation that underscored the value of dermoscopy in identifying the underlying lesion.

14PubMed Central. Basal cell carcinoma with halo phenomenon in a young female: significance of dermatoscopy in early diagnosis

A literature review found that a related phenomenon, sometimes called the Meyerson halo, can occur around a wide range of non-melanocytic lesions including dermatofibromas, vascular growths, keratinocytic tumors, and even scars.

15Case Reports in Dermatology. Dermatofibroma with Hypopigmented Meyerson Halo: A Case Report and Review of Non-Melanocytic Hosts

These non-melanocytic halos are rare enough that they can catch clinicians off guard. A pale ring around a skin lesion primes most dermatologists to think “halo nevus” reflexively. When the central lesion turns out to be something other than a mole, the clinical significance changes entirely. A halo around a basal cell carcinoma, for example, does not mean the cancer is being rejected by the immune system in any therapeutically meaningful way. It simply means the immune response is present, and the underlying lesion still needs standard treatment. The phenomenon also appears in animals: dogs, cats, and horses develop vitiligo-like depigmentation that mirrors the human condition in many respects, suggesting the immune pathways involved are deeply conserved across species.

16PubMed Central. Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: vitiligo and the uveodermatological syndrome: a comprehensive review

The Many Names for One Condition

If you look up halo nevi in medical literature, you will encounter a confusing thicket of synonyms. The condition has been called Sutton nevus (after the dermatologist who described it), leukoderma acquisitum centrifugum, leukopigmentary nevus, perinevoid vitiligo, and perinevoid leukoderma. These all refer to the same thing.

17PubMed Central. Current Challenges in Deciphering Sutton Nevi-Literature Review and Personal Experience

Along with vitiligo and melanoma-associated depigmentation, halo nevi fall under the broader umbrella of immunological leukodermas, conditions where the immune system causes loss of skin pigment. The shared classification reflects genuine immunological overlap, but the clinical behavior and prognosis of these conditions differ enough that lumping them together can mislead patients. A teenager whose dermatologist mentions “immunological leukoderma” in the context of a halo nevus may panic unnecessarily if they then search the term and find it grouped alongside melanoma-associated depigmentation. Context matters: in most people, a halo nevus is simply the immune system tidying up a mole it has decided should not be there.